CC BY-NC-ND 4.0 · J Lab Physicians 2020; 12(02): 115-120
DOI: 10.1055/s-0040-1716454
Original Article

A Hospital-Based Insight into the Antinuclear Antibody Patterns in Autoimmune Disorders

Prishni Gupta
1   Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Ritu Priya
1   Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
1   Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Suprava Patel
1   Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
Eli Mohapatra
1   Department of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India
› Author Affiliations


Background The incidence of autoimmune disorders has seen a rise in India in recent times. The symptoms and signs of these conditions are caused by a systemic autoimmune response, essentially characterized by the expression of the antinuclear antibodies (ANA). Presence of ANA in serum of patient could be the prime evidence of an autoimmune disorder.

Aim This study aimed to determine the antibody patterns and assess the clinical significance of ANA in patients of a teaching tertiary care hospital of central India.

Material and Methods This retrospective cross-sectional data analysis study retrieved 538 reports of individuals, who were prescribed the ANA test by indirect immunofluorescence assay over a period of 11 months, from the archives of the Department of Biochemistry. For continuous data, student t-test was used while Chi-square and Fisher exact was conducted for categorical data. A p value less than 0.05 were taken as significant.

Results Out of the 538 patients investigated for ANA testing by indirect immunofluorescence assay, 33% were positive, among which 74% were female, and majority belonged to the young adult age group. The most common pattern identified was nuclear, subpattern nuclear speckled.

Conclusion A high-ANA pattern positivity could be related to a high-autoimmunity prevalence in this region, and also promotes its use as a tool of evidence of suspected autoimmune disorders.

Supplementary Material

Publication History

Article published online:
02 September 2020

© .

Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India

  • References

  • 1 Elena M, Hernández-becerril N, Perez-chiney AC. et al. Results in Immunology Predictive value of antinuclear antibodies in autoimmune diseases classified by clinical criteria: analytical study in a specialized health institute, one year follow-up. Results Immunol 2015; 5: 13-22
  • 2 Satoh M, Chan EKL, Ho LA, Rose M, Parks CG, Cohn RD. et al. Study design. 2013; 64 (07) 2319-27
  • 3 Gautam K. Anti-Nuclear antibodies: current concepts and future direction for diagnosing connective tissue disease. Journal of Pathology of Nepal 2015; 5: 766-773
  • 4 Akmatov MK, Röber N, Ahrens W. et al. Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders-findings of a multicenter population-based study. Arthritis Res Ther 2017; 19 (01) 127
  • 5 Kumar Y, Bhatia A, Minz RW. Antinuclear antibodies and their detection methods in diagnosis of connective tissue diseases: a journey revisited. Diagn Pathol 2009; 4: 1
  • 6 Minz RW, Kumar Y, Anand S. et al. Antinuclear antibody positive autoimmune disorders in North India: an appraisal. Rheumatol Int 2012; 32 (09) 2883-2888
  • 7 Peene I, Meheus L, Veys EM. De Keyser F. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001; 60 (12) 1131-1136
  • 8 Sebastian W, Roy A, Kini U, Mullick S. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario. Indian J Pathol Microbiol 2010; 53 (03) 427-432
  • 9 Mengeloglu Z, Tas T, Kocoglu E, Aktas G, Karabörk S. Determination of anti-nuclear antibody pattern distribution and clinical relationship. Pak J Med Sci 2014; 30 (02) 380-383
  • 10 Ag S, Afsar I. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods 0: four years 0 data from Turkey. APMIS 2014; 122 (12) 1167-1170
  • 11 Prapinjumrune C, Prucktrakul C, Sooktonglarng T, Thongprasom K. Serum antinuclear antibody in adult Thais. Gerodontology 2017; 34 (01) 86-89
  • 12 Guo YP, Wang CG, Liu X. et al. The prevalence of antinuclear antibodies in the general population of china: a cross-sectional study. Curr Ther Res Clin Exp 2014; 76: 116-119
  • 13 Atassi MZ, Casali P. Molecular mechanisms of autoimmunity. Autoimmunity 2008; 41 (02) 123-132
  • 14 Birnbaum LS, Jusko TA, Kissling GE. et al. HHS public access. J Immigr Minor Health 2015; (919) 1-21
  • 15 Hayter SM, Cook MC. Autoimmunity reviews updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 2012; 11 (10) 754-765
  • 16 Beeson PB. Age and sex associations of 40 autoimmune diseases. Am J Med 1994; 96 (05) 457-462
  • 17 Vermeersch P, Bossuyt X. Autoimmunity reviews prevalence and clinical significance of rare antinuclear antibody patterns. Autoimmun Rev 2013; 12 (10) 998-1003